Proliferative activity of the epithelium in squamous epithelial lesions of the cervix

Abstract

As a criterion for precancerous changes in the stratified squamous epithelium of the cervix, its proliferative activity, studied using monoclonal antibodies PC-10 to the antigen of proliferating cell nuclei (PCNA), is considered. The results of the studies showed that patients with a low degree of squamous intraepithelial lesion are characterized by weak proliferative activity, and for patients with a high degree of lesion it is moderate and pronounced. An increase in proliferative activity is a prognostic factor that determines long-term persistence and the likely progression of the lesion.

Keywords

proliferative activity of the epithelium / monoclonal antibodies PC-10

References

[1] Crook Т., Wrede D., Tidy J. A. et al. Clonal p53 mutation in primary cervical cancer association with human papillomavirus negative tumoura//Lancet. - 1992. No. 339. -P. 1070-1073.

[2] Dellas A., Schultheiss E., Almendral A.C. et al. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia // Int. J. Cancer. - 1997. - Vol. 74. - No. 4. -P. 421-425.

[3] Dias E.P., Gouvea A.L., Eyer C.C. Condyloma acuminatum: its histopathological pattern // Rev. Paul. Med. - 1997, Mar-Apr. - Vol. 115. - No. 2. - P. 1383-1389.

[4] Pim D., Labrecque S. et al. DNA damage induced p53 mediated transcription is inhibited by human papillomavirus type 18E6// Oncogene. -1994. - Vol. 9. - P. 629- 633.

[5] Haba T, Enomoto T, Fujita M. et al. Clonal analysis of cervical intraepithelial neoplasia //Abstract Proc. Annu Meet. Am. Assoc. Cancer Res. - 1997. - P. 38 (A 717).

[6] Ho G.Y., Burk R.D., Klein S. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia//J. Natl. Cancer Inst.- 1995. - Vol. 87. - P. 1365-1371.

[7] Lane S., Wells M. Human papillomaviruses, p53 and cervical neoplasia //J. Pathol. - 1994. - Vol. 172. - P. 299-300.

[8] Lassus J., Ranki A. Simultaneously detected aberrant p53 tumor supressor protein and HPV-DNA localize mostly in separate keratinocytes in anogenital and common warts // Experiment.

[9] Dermatol. - 1996. - Vol. 5. - No. 2. - P. 72-78.

[10] Lungu O., SunX.W., Felix J. etal. Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia // JAMA. - 1992. - Vol. 267. - P. 2493-2496.

[11] Midgeley C.A., Fisher C. J., Bartek J. et al. Analysis of p53 expression in human tumours: An antibody raised against human p53 expressed in Escherichia coli // J. Cell. Sci. - 1992. - No. 101. - P. 183-189.

[12] Mitchell M.F., Schottenfeld D. The natural history of CIN and management of the abnormal Papanicolaou smear // Rubin S.C, Hoskins W.J. (eds). Cervical cancer and preinvasive neoplasia. - New York: Lippincott-Raven., 1996. - P. 103-113.

[13] Mittal K., Demopoulos R.I., Tata M. A comparison of proliferative activity and atypical mitosis in cervical condylomas with various HPV types // Int. J. Gynaecol. Pathol. - 1998, Jan. - Vol. 17.- No. 1.-P. 24-28.

[14] Park D.G., Wilczynski S.P., Paquette R.L. et al. P53 mutations in HPV-negative cervical carcinoma // Oncogene. - 1994. - Vol. 9 - P. 205- 210.

[15] RihetS., Lorenzato M., Clavel C. Oncogenic human papillomaviruses and ploidy in cervical lesions // J. Clin. Pathol. - 1996. - Vol. 49. - No. 11.-P. 892-896.

[16] Woodworth C.D., Wang H., Simpson S. et al. Overexpression of wild-type p53 alters growth and differentiation of normal human keratinocytes but no human papillomavirus-expressing cell lines // Cell. Growth. Differ. - 1993. - Vol.4. - P. 367-376.

RIGHTS & PERMISSIONS

Eсо-Vector